Skip to Content
Merck
CN

Key Documents

View All Documentation

EMU073061

MISSION® esiRNA

targeting mouse Malt1

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TCACAGCTGGATGTGTGTGATGTGGCAGAAGTAACAGACAGCTTCCAGGGAAGTATGGATGGCATCTCAGAATCCAGGTTGCAAATCTGTGTTGAACCAAGGTCCCAAAGGCTGGTGCCAGGCAGCATGTTGTTGTTACAGTGTGTTGCTATTGGAAGTCCTATGCCTCACTACCAGTGGTTTAAAGATGAATCACCATTAACACATGAGACAAAAAAGCACTACACGGTTCCATATGTGGATATAGAACATGAAGGAACCTACTGGTGTCATGTATATAATGACCGAGACAGTCAAGATAGCAAGAAGGCAGAAGTCACCATAGATGAATTAAACAATTTGGGGCATCCTGATAATAAAGAACAAACTGGCCAGCCTTTGGCAAAGGACAAAGTCGCCCTTTTGATAGGGAATATGAGTTACTGGGAGCATCCC

Ensembl | mouse accession no.

ENSMUSG00000032688

NCBI accession no.

NM_172833

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... MALT1(240354), Malt1(240354)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Matija Hedl et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(37), 13451-13456 (2014-09-10)
Inflammatory diseases are characterized by dysregulated cytokine production. Altered functions for most risk loci, including the inflammatory bowel disease and leprosy-associated tumor necrosis factor ligand superfamily member 15 (TNFSF15) region, are unclear. Regulation of pattern-recognition-receptor (PRR)-induced signaling and cytokines is

Global Trade Item Number

SKUGTIN
EMU073061-50UG04061828257034
EMU073061-20UG04061828482313